Discovery platform for inhibitors of IgH gene enhancer activity

References

• Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene. 2001;20:5611–5622. doi:10.1038/sj.onc.1204641.
   PubMed Web of Science ®Google Scholar
• Tiedemann RE, Gonzalez-Paz N, Kyle RA, Santana-Davila R, Price-Troska T, Van Wier SA, Al E, Ketterling RP, Gertz MA, Henderson K, et al. Genetic aberrations and survival in plasma cell leukemia. Leukemia. 2008;22:1044–1052. doi:10.1038/leu.2008.4.
   PubMed Web of Science ®Google Scholar
• Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20:5580–5594. doi:10.1038/sj.onc.1204640.
   PubMed Web of Science ®Google Scholar
• Bernicot I, Douet-Guilbert N, Le Bris MJ, Morice P, Abgrall JF, Berthou C, Morel F, De Braekeleer M. Characterization of IGH rearrangements in non-Hodgkin’s B-cell lymphomas by fluorescence in situ hybridization. Anticancer Res. 2005;25:3179–3182.
   PubMed Web of Science ®Google Scholar
• Hayman SR, Bailey RJ, Jalal SM, Ahmann GJ, Dispenzieri A, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Rajkumar SV, et al. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood. 2001;98:2266–2268.
   PubMed Web of Science ®Google Scholar
• Perfetti V, Coluccia AM, Intini D, Malgeri U, Vignarelli MC, Casarini S, Merlini G, Neri A. Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis. Am J Pathol. 2001;158:1599–1603. doi:10.1016/S0002-9440(10)64115-6.
   PubMed Web of Science ®Google Scholar
• Bochtler T, Hegenbart U, Cremer FW, Heiss C, Benner A, Hose D, Moos M, Bila J, Bartram CR, Ho AD, et al. Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Blood. 2008;111:4700–4705. doi:10.1182/blood-2007-11-122101.
   PubMed Web of Science ®Google Scholar
• Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Kumar S, Kyle RA, Fonseca R, Greipp PR, Lust JA, et al. A novel report of cig-FISH and cytogenetics in POEMS syndrome. Am J Hematol. 2008;83:840–841. doi:10.1002/ajh.21285.
   PubMed Web of Science ®Google Scholar
• Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2:920–932. doi:10.1038/nri953.
   PubMed Web of Science ®Google Scholar
• Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005;23:6333–6338. doi:10.1200/JCO.2005.05.021.
   PubMed Web of Science ®Google Scholar
• Schmitz R, Renne C, Rosenquist R, Tinguely M, Distler V, Menestrina F, Lestani M, Stankovic T, Austen B, Bräuninger A, et al. Insights into the multistep transformation process of lymphomas: igH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin’s and non-Hodgkin’s lymphomas. Leukemia. 2005;19:1452–1458. doi:10.1038/sj.leu.2403841.
   PubMed Web of Science ®Google Scholar
• Chesi M, Bergsagel PL. Many multiple myelomas: making more of the molecular mayhem. Hematology Am Soc Hematol Educ Program. 2011;2011:344–353. doi:10.1182/asheducation-2011.1.344.
   PubMedGoogle Scholar
• Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S, Middha S, Asmann Y, Schmidt J, Braggio E, et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 2012;120:1060–1066. doi:10.1182/blood-2012-01-405977.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117:211–220. doi:10.1182/blood-2010-07-298349.
   PubMed Web of Science ®Google Scholar
• Raje N, Hideshima T, Mukherjee S, Raab M, Vallet S, Chhetri S, Cirstea D, Pozzi S, Mitsiades C, Rooney M, et al. Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma. Leukemia. 2009;23:961–970. doi:10.1038/leu.2008.378.
   PubMed Web of Science ®Google Scholar
• Mouse Genome Sequencing C, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520–562. doi:10.1038/nature01262.
   PubMed Web of Science ®Google Scholar
• Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature. 2009;461:199–205. doi:10.1038/nature08451.
   PubMed Web of Science ®Google Scholar
• Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. Architecture of the human regulatory network derived from ENCODE data. Nature. 2012;489:91–100. doi:10.1038/nature11245.
   PubMed Web of Science ®Google Scholar
• Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vermot B, et al. The accessible chromatin landscape of the human genome. Nature. 2012;489:75–82. doi:10.1038/nature11232.
   PubMed Web of Science ®Google Scholar
• Neph S, Vierstra J, Stergachis AB, Reynolds AP, Haugen E, Vernot B, Thurman RE, John S, Sandstrom R, Johnson AK, et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature. 2012;489:83–90. doi:10.1038/nature11212.
   PubMed Web of Science ®Google Scholar
• Yancopoulos GD, Alt FW. Regulation of the assembly and expression of variable-region genes. Annu Rev Immunol. 1986;4:339–368. doi:10.1146/annurev.iy.04.040186.002011.
   PubMed Web of Science ®Google Scholar
• Staudt LM, Lenardo MJ. Immunoglobulin gene transcription. Annu Rev Immunol. 1991;9:373–398. doi:10.1146/annurev.iy.09.040191.002105.
   PubMed Web of Science ®Google Scholar
• Vincent-Fabert C, Fiancette R, Pinaud E, Truffinet V, Cogne N, Cogne M, Denizot Y. Genomic deletion of the whole IgH 3ʹ regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood. 2010;116:1895–1898. doi:10.1182/blood-2010-01-264689.
   PubMed Web of Science ®Google Scholar
• Kuzin II, Bagaeva L, Young FM, Bottaro A. Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation. J Immunol. 2008;180:7443–7450.
   PubMed Web of Science ®Google Scholar
• Corcoran LM, Cory S, Adams JM. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell. 1985;40:71–79.
   PubMed Web of Science ®Google Scholar
• Wang J, Boxer LM. Regulatory elements in the immunoglobulin heavy chain gene 3ʹ-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. J Biol Chem. 2005;280:12766–12773. doi:10.1074/jbc.M412446200.
   PubMed Web of Science ®Google Scholar
• Dildrop R, Ma A, Zimmerman K, Hsu E, Tesfaye A, DePinho R, Alt Fw. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. Embo J. 1989;8:1121–1128.
   PubMed Web of Science ®Google Scholar
• Dolloff NG, Allen JE, Dicker DT, Aqui N, Vogl D, Malysz J, Talamo G, El-Deiry WS. Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9. Mol Cancer Ther. 2012;11:2321–2330. doi:10.1158/1535-7163.MCT-12-0578.
   PubMed Web of Science ®Google Scholar
• Tantin D, Sharp PA. Mouse lymphoid cell line selected to have high immunoglobulin promoter activity. Mol Cell Biol. 2002;22:1460–1473.
   PubMed Web of Science ®Google Scholar
• Mills FC, Fisher LM, Kuroda R, Ford AM, Gould HJ. DNase I hypersensitive sites in the chromatin of human mu immunoglobulin heavy-chain genes. Nature. 1983;306:809–812.
   PubMed Web of Science ®Google Scholar
• Rabbitts TH, Forster A, Baer R, Hamlyn PH. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. Nature. 1983;306:806–809.
   PubMed Web of Science ®Google Scholar
• Calame K, Sen R. Chapter 6 - Transcription of Immunoglobulin Genes. In: Neuberger THWAS, editor Molecular Biology of B Cells. Burlington (MA, USA): Academic Press; 2003. p. 83–100.
   Google Scholar
• Banerji J, Olson L, Schaffner W. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell. 1983;33:729–740.
   PubMed Web of Science ®Google Scholar
• Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 1983;33:717–728.
   PubMed Web of Science ®Google Scholar
• Cheung WC, Kim JS, Linden M, Peng L, Van Ness B, Polakiewicz RD, Janz S. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J Clin Invest. 2004;113:1763–1773. doi:10.1172/JCI20369.
   PubMed Web of Science ®Google Scholar
• Boylan KL, Gosse MA, Staggs SE, Janz S, Grindle S, Kansas GS, Van Ness BG. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma. Cancer Res. 2007;67:4069–4078. doi:10.1158/0008-5472.CAN-06-3699.
   PubMed Web of Science ®Google Scholar
• Gonzalez D, Gonzalez M, Balanzategui A, Sarasquete ME, Lopez-Perez R, Chillon MC, García-Sanz R, San Miguel JF. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma. Haematologica. 2005;90:906–913.
   PubMed Web of Science ®Google Scholar
• Wuerffel R, Wang L, Grigera F, Manis J, Selsing E, Perlot T, Alt FW, Cogne M, Pinaud E, Kenter AL. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity. 2007;27:711–722. doi:10.1016/j.immuni.2007.09.007.
   PubMed Web of Science ®Google Scholar
• Pinaud E, Khamlichi AA, Le Morvan C, Drouet M, Nalesso V, Le Bert M, Al E. Localization of the 3ʹ IgH locus elements that effect long-distance regulation of class switch recombination. Immunity. 2001;15:187–199.
   PubMed Web of Science ®Google Scholar
• Lieberson R, Ong J, Shi X, Eckhardt LA. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. Embo J. 1995;14:6229–6238.
   PubMed Web of Science ®Google Scholar
• Bobo B, Phelan D, Rebhahn J, Piepenbrink MS, Zheng B, Mosmann TR, Kobie JJ, DeLouise LA. Microbubble array diffusion assay for the detection of cell secreted factors. Lab Chip. 2014;14:3640–3650. doi:10.1039/c4lc00580e.
   PubMed Web of Science ®Google Scholar
• Stessman HA, Lulla A, Xia T, Mitra A, Harding T, Mansoor A, Myers CL, Van Ness BG, Dolloff NG. High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma. Leukemia. 2014;28:2263–2267. doi:10.1038/leu.2014.214.
   PubMed Web of Science ®Google Scholar
• Krem MM, Press OW, Horwitz MS, Tidwell T. Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy. Br J Haematol. 2015;171:13–28. doi:10.1111/bjh.13507.
   PubMed Web of Science ®Google Scholar
• Cancer facts & figures 2015. Atlanta (GA, USA): American Cancer Society; 2015.
   Google Scholar
• Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7:233–245. doi:10.1038/nrc2091.
   PubMed Web of Science ®Google Scholar
• Matthias P. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?. Semin Immunol. 1998;10:155–163. doi:10.1006/smim.1998.0117.
   PubMed Web of Science ®Google Scholar
• Roy AL, Sen R, Roeder RG. Enhancer-promoter communication and transcriptional regulation of Igh. Trends Immunol. 2011;32:532–539. doi:10.1016/j.it.2011.06.012.
   PubMed Web of Science ®Google Scholar
• Tang H, Sharp PA. Transcriptional regulation of the murine 3ʹ IgH enhancer by OCT-2. Immunity. 1999;11::517–526.
   PubMed Web of Science ®Google Scholar
• Luo Y, Fujii H, Gerster T, Roeder RG. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell. 1992;71:231–241.
   PubMed Web of Science ®Google Scholar
• Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M, Roeder RG. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature. 1996;383:542–547. doi:10.1038/383542a0.
   PubMed Web of Science ®Google Scholar
• Stevens S, Ong J, Kim U, Eckhardt LA, Roeder RG. Role of OCA-B in 3ʹ-IgH enhancer function. J Immunol. 2000;164:5306–5312.
   PubMed Web of Science ®Google Scholar
• Ren X, Siegel R, Kim U, Roeder RG. Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication. Mol Cell. 2011;42:342–355. doi:10.1016/j.molcel.2011.04.011.
   PubMed Web of Science ®Google Scholar
• Duan H, Xiang H, Ma L, Boxer LM. Functional long-range interactions of the IgH 3ʹ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. Oncogene. 2008;27:6720–6728. doi:10.1038/onc.2008.286.
   PubMed Web of Science ®Google Scholar
• Bain G, Gruenwald S, Murre C. E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol. 1993;13:3522–3529.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Ju Z, Hassan R, Volpi SA, Emelyanov AV, Birshtein BK. Dynamic changes in binding of immunoglobulin heavy chain 3ʹ regulatory region to protein factors during class switching. J Biol Chem. 2011;286:29303–29312. doi:10.1074/jbc.M111.243543.
   PubMed Web of Science ®Google Scholar
• Liu H, Schmidt-Supprian M, Shi Y, Hobeika E, Barteneva N, Jumaa H, Pelanda R, Reth M, Skok J, Rajewsky K, et al. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev. 2007;21:1179–1189. doi:10.1101/gad.1529307.
   PubMed Web of Science ®Google Scholar
• Gordon SJ, Saleque S, Birshtein BK, Yang Y. 1 is a lipopolysaccharide-inducible activator of the murine 3ʹ Igh enhancer, hs3. J Immunol. 2003;170:5549–5557.
   PubMed Web of Science ®Google Scholar
• Garrett FE, Emelyanov AV, Sepulveda MA, Flanagan P, Volpi S, Li F, Loukinov D, Eckhardt LA, Lobanenkov VV, Birshtein BK. Chromatin architecture near a potential 3ʹ end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites. Mol Cell Biol. 2005;25:1511–1525. doi:10.1128/MCB.25.4.1511-1525.2005.
   PubMed Web of Science ®Google Scholar
• Lu ZP, Ju ZL, Shi GY, Zhang JW, Sun J. Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription. Biochem Biophys Res Commun. 2005;330:204–209. doi:10.1016/j.bbrc.2005.02.147.
   PubMed Web of Science ®Google Scholar
• Tusi BK, Deng C, Salz T, Zeumer L, Li Y, So CW, Morel LM, Qiu Y, Huang S. Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement. FASEB J. 2015;29:1505–1515. doi:10.1096/fj.14-263061.
   PubMed Web of Science ®Google Scholar
• Michaelson JS, Singh M, Snapper CM, Sha WC, Baltimore D, Birshtein BK. Regulation of 3ʹ IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol. 1996;156:2828–2839.
   PubMed Web of Science ®Google Scholar
• Sepulveda MA, Emelyanov AV, Birshtein BK. NF-kappa B and Oct- 2synergize to activate the human 3ʹ Igh hs4 enhancer in B cells. J Immunol. 2004;172:1054–1064.
   PubMed Web of Science ®Google Scholar